MRA PRAISES DRUG APPROVAL IN JAPAN AS “GAME-CHANGING” WASHINGTON, D.C., July 7, 2014 – The Melanoma Research Alliance (MRA) today applauded the news that Japanese drug regulators granted approval to nivolumab, mark

Source URL: curemelanoma.org

• Cancer immunotherapy
• Immunotherapy
• Skin cancer
• Michael Milken
• Breast cancer
• Medicine
• Oncology
• Melanoma